Financhill
Back

Recursion Pharmaceuticals Vs. First Solar Industry Stock Comparison

Buy
57

RXRX
Recursion Pharmaceuticals

Last Price:
$5.49
Seasonality Move:
7.58%
Sell
47

FSLR
First Solar

Last Price:
$166.42
Seasonality Move:
9.64%
Buy
57
Recursion Pharmaceuticals (RXRX) is a Buy

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

  • The current Recursion Pharmaceuticals [RXRX] share price is $5.49. The Score for RXRX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • RXRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
First Solar (FSLR) is a Sell

Is First Solar a Buy, Sell or Hold?

  • The current First Solar [FSLR] share price is $166.35. The Score for FSLR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • FSLR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

  • The Recursion Pharmaceuticals share price today is $5.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

FSLR Stock Price Chart

What is First Solar's stock price today?

  • The First Solar share price today is $166.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FSLR is experiencing buying pressure, which is a positive indicator for future bullish movement.

RXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 61.38 Buy
Chaikin Money Flow: 55882068 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.11 - 4.87) Buy
Bollinger Bands (100): (4.57 - 7.67) Sell

FSLR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.46 Buy
Relative Strength Index (14 RSI): 58.37 Buy
Chaikin Money Flow: 1574364 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (138.99 - 175.37) Buy
Bollinger Bands (100): (128.69 - 169.67) Buy

RXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.59 Buy
20-day SMA: 4.46 Buy
50-day SMA: 4.89 Buy
200-day SMA: 6.47 Sell
8-day EMA: 4.71 Buy
20-day EMA: 4.63 Buy
50-day EMA: 5.06 Buy
200-day EMA: 6.42 Sell

FSLR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 158.69 Buy
20-day SMA: 164.08 Buy
50-day SMA: 143.37 Buy
200-day SMA: 178.96 Sell
8-day EMA: 160.87 Buy
20-day EMA: 157.68 Buy
50-day EMA: 151.15 Buy
200-day EMA: 167.9 Sell

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.25 per share.

First Solar Earnings Growth & FSLR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.27 per share, an increase next quarter of $0.58 per share, an increase this year of $2.11 per share, and an increase next year of $8.76 per share.

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

First Solar Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):